Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone shows strong support and interest, with phrases like 'groundbreaking study' and 'new hope for COPD treatment,' emphasizing excitement around the research. Posts reference specific results, such as reduction in airway inflammation and increased NAD+ levels, which demonstrate a focus on scientific details and potential implications, reflecting a moderate but meaningful level of engagement and perceived impact.
Most discussions highlight the positive findings of the study, suggesting a general consensus of agreement with the potential benefits of nicotinamide riboside (NR) for COPD inflammation reduction.
The exploration of NR as a new treatment avenue and mentions of 'groundbreaking' findings indicate high interest among participants.
Many posts share detailed summaries or highlight the significance of the study, implying a moderate level of engagement and curiosity.
While the findings are seen as promising, the discussions mainly focus on potential and preliminary results rather than definitive clinical impact.
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial “Our study demonstrates that supplementation with NR reduced airway inflammation and increased NAD+ levels in whole blood…” @ScheibyeKnudsen https://t.co/nIIFbZM229 https://t.co/9VRiU7vClp
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial https://t.co/ESQuPmLZWb
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial. Nicotinamide riboside shows that it has anti-inflammatory effects. This is the most consistent effect of NR supplementation. https://t.co/ZK8zbEjE3e
RT @agingdoc1: Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial “Our study demonstra…
New Advances in NR Anti-Inflammatory Activity? This study on Nature Aging shows that #NR reduces airway inflammation in COPD. By Kristoffer L. Norheim, Celeste Porsbjerg et al. https://t.co/M59GWTqxu1 https://t.co/ximaxuhoQP
4.B3 Vitaminiyle KOAH’ a Yeni Umut Kaynak: DOI: 10.1038/s43587-024-00758-1 5.Uyku Beyni Nasıl Güçlendiriyor? Yeni Araştırma Sırlarını Ortaya Çıkardı! Kaynak: https://t.co/hul5g9gKao #gencivek #bilimdebuhafta
In a study, high-dose vitamin B3 reduced inflammation markers in COPD patients. After 6 weeks, a 53% decrease in IL8 was observed, increasing to 63% at 12 weeks. The research suggests NR could be a promising therapy for…
Researchers investigated high-dose vitamin B3's effects on COPD inflammation, showing significant reductions in IL8 levels. The study suggests that nicotinamide riboside may help reduce airway inflammation and improve…
Is Nicotinamide Riboside the Future of COPD Treatment? Ep. 1221 DEC 24 https://t.co/FNvRpIfAAD via @YouTube
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial https://t.co/ESQuPmLZWb
Is Nicotinamide Riboside the Future of COPD Treatment? #trailer https://t.co/hmKCglkFar via @YouTube In a groundbreaking study, researchers explored the potential of high-dose vitamin B3 to combat inflammation in COPD. The study involved 40 COPD patients who were given eithe
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial. Nicotinamide riboside shows that it has anti-inflammatory effects. This is the most consistent effect of NR supplementation. https://t.co/ZK8zbEjE3e
RT @agingdoc1: Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial “Our study demonstra…
4.B3 Vitaminiyle KOAH’ a Yeni Umut Kaynak: DOI: 10.1038/s43587-024-00758-1 5.Uyku Beyni Nasıl Güçlendiriyor? Yeni Araştırma Sırlarını Ortaya Çıkardı! Kaynak: https://t.co/hul5g9gKao #gencivek #bilimdebuhafta
New Advances in NR Anti-Inflammatory Activity? This study on Nature Aging shows that #NR reduces airway inflammation in COPD. By Kristoffer L. Norheim, Celeste Porsbjerg et al. https://t.co/M59GWTqxu1 https://t.co/ximaxuhoQP
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial https://t.co/Oc7LIuJWPT
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial “Our study demonstrates that supplementation with NR reduced airway inflammation and increased NAD+ levels in whole blood…” @ScheibyeKnudsen https://t.co/nIIFbZM229 https://t.co/9VRiU7vClp